By reducing MHC expression, cancer cells can evade recognition by cytotoxic T cells, which rely on MHC-antigen complexes to identify and eliminate abnormal cells (Alos et al., 2020; Wang et al., 2024). This evidence concerns the gene HLA-C and cancer.